CELL AND GENE THERAPY LTD.
Significant control: Vladimir Gamolskiy (significant control)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Cell And Gene Therapy Ltd.: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Cell And Gene Therapy Ltd. sell?
Registered activity: Other professional, scientific and technical activities n.e.c. (SIC 74909). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
CELL AND GENE THERAPY LTD. is an active private limited company (company number 09415326) incorporated on 30 January 2015, registered in London. Its registered activity is other professional, scientific and technical activities n.e.c. (SIC 74909). Latest micro accounts cover the period ending 31 January 2025, showing net assets of £7,203, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets were unchanged on the prior period.
By net assets it sits in the upper half of 7,601 comparable companies in London (median £3,258, upper quartile £44k).
Ownership and control
- Mr Vladimir Gamolskiy
- has significant influence or control
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 30 January 201511 yrs ago
- Next accounts due
- 31 October 2026in 4 days
- Confirmation statement due
- 13 February 2027in 109 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 74909
- Other professional, scientific and technical activities n.e.c.
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 January 2025 | £7,203 | — | — | — | — | — | 1 |
| 31 January 2024 | £7,203 | — | — | — | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets above zeroNet assets £7,203 at 31 January 2025
- Incorporated five or more years agoIncorporated 30 January 2015
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 109 days
- Next accounts duein 4 days
- Accounts period endNet assets £7,203 · micro accounts
- Accounts period endNet assets £7,203 · micro accounts
- Incorporated
Similar companies in London
- MARK BAIGENT CONSULTING LTDLondon · inc. Jan 2015
- JO GILLINGWATER LIMITEDLondon · inc. Jan 2015
- LIMEBLISS LIMITEDLondon · inc. Jan 2015
- VELADOR ASSOCIATES LTDLondon · inc. Jan 2015
- SINNOVA LTDLondon · inc. Jan 2015
- DEPAUL GROUP TRADING LIMITEDLondon · inc. Jan 2015
All companies incorporated on 30 January 2015 · in Jan 2015.
Reminders for CELL AND GENE THERAPY LTD.
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.